Skip to content
Home›Awards›Locus Biosciences INC
$

Federal Contract Award

Locus Biosciences INC

Department of Health and Human Services · September 16, 2025 · FY2025

75A50120C00169Full & OpenNAICS 541714

Obligated

$73,885,104

Contract details

Award ID
CONT_AWD_75A50120C00169_7505_-NONE-_-NONE-
PIID
75A50120C00169
Period of performance
September 28, 2020 → December 31, 2026
Place of performance
MORRISVILLE, NC, USA
Set-aside
None (Full & Open)
Pricing type
COST SHARING
PSC
AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
NAICS
541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

Scope

CLINICAL DEVELOPMENT OF CRISPR-CAS3 PHAGE COCKTAIL FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS CAUSED BY ESCHERICHIA COLI INCLUDING ANTIMICROBIAL AND MULTI-DRUG RESISTANT STRAINS

Parent vehicle (IDV)

Locus Biosciences INC

UEI CJKVLKZGX6F3

This award was placed as a task/delivery order under a larger contract vehicle.

Recipient

Locus Biosciences INC →
UEI
CJKVLKZGX6F3
CAGE
7H2T2
Parent
Locus Biosciences INC
Address
MORRISVILLE, NC

Awarding agency

Department of Health and Human Services →
Sub-agency
Office of Assistant Secretary for Preparedness and Response
Office
BARDA - ASPR / DAAPPO / BARDA DCMA
Funding agency
Department of Health and Human Services
Funding office
BARDA - ASPR / DAAPPO / BARDA DCMA

See every contract Locus Biosciences INC has won

Full contracting history, year-over-year trends, subaward graph, and recompete alerts.

View Locus Biosciences INC profile →